Skip to main content
. 2018 Oct 23;8:15615. doi: 10.1038/s41598-018-33689-0

Figure 1.

Figure 1

c-Fos expression in human sarcoma samples. (AC) Co-expression studies of FOS with other genes in a cohort with 259 sarcoma samples. (See Dataset 1 in Supplementary Materials and methods). (A,B Pearson correlation study, p < 0.01). (A) Example of positive correlation between FOS and JUNB gene expression. Each dot represents a sarcoma sample. (B) Example of negative correlation between FOS and BRCA1 gene expression. Each dot represents a sarcoma sample. (C) Gene ontology (GO) study of FOS correlated genes (chi-square with continuity correction study, p < 0.01). A list of significant GO terms with the p-values is provided. The number on the right of each GO term represent the number of genes observed for that GO term. (D) Representative images of performed c-Fos IHC in clinical samples of human sarcomas (Chondrosarcoma n = 29, Osteosarcoma n = 67). (E) Table summarizing the presence of c-Fos in clinical samples of human sarcomas (Fisher’s exact test, p < 0.01). (F,G) c-Fos expression at mRNA level in different sarcoma tumors (*p ≤ 0.1). (F) data extracted from dataset 2, a cohort with 21 sarcoma samples, and normalized to c-Fos expression in growth plate (GP) controls included in the same dataset. (G) data from 19 sarcoma samples extracted from dataset 3 and normalized to HSP90 expression in each patient.